These last observations, the significant difference in the levels of both metabolites and the previously observed stability of the Fe(II) sulfonium species versus the instability of the Fe(II) sulfheme species under oxidative conditions (Fig. 5), open up new possibilities for the inhibition of catalase bioactivity in cancers through HCys-induced sulfheme generation. The gene discussed is CAT; the disease is cancer.